✦ LIBER ✦

RANOLAZINE FOR THE TREATMENT OF DIASTOLIC HEART FAILURE IN PATIENTS WITH PRESERVED EJECTION FRACTION: RESULTS FROM THE RALI-DHF STUDY

✍ Scribed by Lars Maier; Rolf Wachter; Frank Edelmann; Beth Layug; Ewa Karwatowska-Prokopczuk; Luiz Belardinelli; Gerd Hasenfuss; Claudius Jacobshagen

Book ID: 118582674
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 90 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60866-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranolazine for the Treatment of Heart Fa

Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI-DHF Study

✍ Claudius Jacobshagen; Luiz Belardinelli; Gerd Hasenfuss; Lars S. Maier 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB

Exercise Training Improves Exercise Capa

Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) Pilot Study

✍ Frank Edelmann; Götz Gelbrich; Hans-Dirk Düngen; Stefan Fröhling; Rolf Wachter; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1002 KB

Does angiotensin receptor blockade impro

Does angiotensin receptor blockade improve outcomes in patients with heart failure and preserved ejection fraction? Results of the I-PRESERVE study

✍ Henry Krum 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 169 KB

BASELINE SYSTOLIC BLOOD PRESSURE AND OUT

BASELINE SYSTOLIC BLOOD PRESSURE AND OUTCOMES IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION - RESULTS FROM THE I-PRESERVE TRIAL

✍ Inderjit S. Anand; Scott J. Hetzel; Alan B. Miller; Peter E. Carson; William H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Chest X-Ray Predicts Outcome in Heart Fa

Chest X-Ray Predicts Outcome in Heart Failure Patients with Preserved and Reduced Ejection Fraction: Analysis from the DIG Study

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Rationale and design of the Treatment of

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

✍ Akshay S. Desai; Eldrin F. Lewis; Rebecca Li; Scott D. Solomon; Susan F. Assmann 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 390 KB